Professor Pier Lambiase (Consultant Electrophysiologist, University College London and Barts Heart Centre, London, UK) joins touchCARDIO at the annual European Heart Rhythm (EHRA) 2019 congress in Lisbon to discuss the risks of sudden cardiac death and new techniques to improve prevention, diagnosis and monitoring.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Professor Pier Lambiase has received research grants from Abbott, Boston Scientific and Medtronic.
- Sudden cardiac death remains a significant global healthcare concern – please explain its risk in patients with non-ischaemic cardiomyopathy. (0:14)
- How can patients with non-ischaemic cardiomyopathy be stratified to help assess risk and improve prevention of sudden cardiac death? (0:39)
- What imaging techniques can be employed to facilitate diagnosis and monitoring? (1:47)
- What are the key factors in improving prevention of sudden cardiac death in patients with non-ischaemic cardiomyopathy? (2:39)
- Please summarise your highlights of the EHRA 2019 congress so far. (3:24)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study
We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!